## Abstract Epithelial ovarian cancer (EOC) is treated mainly by platinumβbased combination chemotherapy. Chemotherapy induces apoptosis in which the Fas/Fas ligand pathway is important. Serum soluble Fas (sFas) is a biomarker of this pathway and functionally inhibits Fasβ/FasLβmediated apoptosis.
Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
β Scribed by G. K. Siddiqui; A. B. Maclean; K. Elmasry; A. Wong te Fong; R. W. Morris; M. Rashid; R. H. J. Begent; G. M. Boxer
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 366 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0969-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The response to epoetin-alpha treatment is hard to predict in cancer patients receiving chemotherapy. ## Methods: One hundred and seventeen patients were enrolled in this observational study. they had a hemoglobin (hb) level less than or equal to 10.5 g/dl, were receiving platinum
## Abstract The objective of this study was to evaluate the role of an __in vitro__ drug resistance assay to platinum and taxane in the management of advanced epithelial ovarian, fallopian and primary peritoneal cancer. All patients with FIGO Stage IIIc and IV who received postoperative chemotherap
## BACKGROUND. Resistance to chemotherapy agents is a major problem in the treatment of patients with nonsmall cell lung carcinoma (NSCLC). Recent studies have indicated that glutathione S-transferase-n (GST-n) may play an important role in the resistance of cancer cells to alkylating agents, inclu